Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-24 @ 10:22 PM
NCT ID:
NCT04544735
Eligibility Criteria:
Cancer Survivors participating in the Intervention Development Interviews
Inclusion Criteria:
* Diagnosis of non-metastatic gynecologic (cervical, endometrial, vaginal, vulvar), anal, rectal, or bladder cancer
* Completed pelvic radiation treatment within the last 5 years
* 18 years of age or older
* Able to speak/read English
* Able to give meaningful informed consent
Exclusion Criteria:
* Major untreated or uncontrolled mental illness (e.g., schizophrenia)
* Unable to provide informed consent
Medical Providers Participating in Intervention Development Interviews
Eligibility Criteria:
* Oncology providers (e.g., radiation, medical, and surgical oncologists; nurses; advanced practice professionals) who provide care to women who receive pelvic radiation for gynecologic, anal, rectal or bladder cancers.
* Physical therapists with specialized certification in pelvic health or women's health physical therapy who provide care to patients in the outpatient setting.
Cancer Survivor User Testers
Inclusion Criteria:
* Diagnosis of non-metastatic gynecologic (cervical, endometrial, vaginal, vulvar), anal, rectal, or bladder cancer
* Completed pelvic radiation treatment in the past 2 to 24 months
* 18 years of age or older
* Able to speak/read English
* Able to give meaningful informed consent
Exclusion Criteria:
* Major untreated or uncontrolled mental illness (e.g., schizophrenia)
* Unable to provide informed consent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04544735
Study Brief:
Protocol Section:
NCT04544735